| Title: |
Closing the gap: do we need a framework for embedding equity in health technology assessment? |
| Authors: |
Pearson-Stuttard, Jonathan; Richardson, Marina; Griffin, Susan; Lübker, Chris; Duffield, Stephen |
| Source: |
International Journal of Technology Assessment in Health Care ; volume 42, issue 1 ; ISSN 0266-4623 1471-6348 |
| Publisher Information: |
Cambridge University Press (CUP) |
| Publication Year: |
2026 |
| Description: |
Objectives Reducing health inequalities and improving health equity have become pressing priorities for health technology assessment (HTA) bodies and healthcare payers globally, particularly in light of the COVID-19 pandemic and its disproportionate impact on disadvantaged groups. Equity considerations are now being embedded across strategic frameworks and HTA processes in countries such as the UK, Canada, and Australia. Examples include NICE’s Core20PLUS5 initiative and PBAC’s policy shift allowing broader prescribing access to address care disparities. However, systematically incorporating quantitative equity measures into HTA presents significant challenges, given the diversity of equity subgroups and varying national contexts. Methods At the 2024 CDA-AMC Symposium, we convened stakeholders to discuss the challenges and opportunities for integrating equity into HTA. Results Key insights included ICER’s framework for embedding equity across the HTA lifecycle and NICE’s evolving application of Distributional Cost-Effectiveness Analysis (DCEA), as demonstrated in the appraisal of exagamglogene autotemcel for beta-thalassemia. DCEA, while increasingly recognized, requires robust real-world data and clearer guidance on trade-offs between equity and efficiency. Manufacturers are aligning equity goals with ESG priorities but seek greater clarity from HTA bodies on how equity evidence influences decision-making. NICE and ICER emphasize the need for deliberative processes to capture equity dimensions not reflected in traditional cost-effectiveness analysis. Conclusion Advancing health equity in HTA will require cross-sector collaboration to develop guidance, improve data infrastructure, and standardize methodologies. Equity-focused evidence generation across the “staircase of inequality” – from need to access and outcomes – can support more inclusive HTA and reimbursement decisions, ultimately fostering a fairer and more effective healthcare system. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1017/s0266462325103322 |
| Availability: |
https://doi.org/10.1017/s0266462325103322; https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0266462325103322 |
| Rights: |
http://creativecommons.org/licenses/by-nc-nd/4.0 |
| Accession Number: |
edsbas.129647E9 |
| Database: |
BASE |